This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa
The drug PRIMOVIST contains one active pharmaceutical ingredient (API):
|
1
Gadoxetic acid
UNII HOY74VZE0M - GADOXETATE DISODIUM
|
|
Gadoxetic acid is a paramagnetic contrast agent for magnetic resonance imaging. The contrast-enhancing effect is mediated by gadoxetate (Gd EOB DTPA), an ionic complex consisting of gadolinium (III) and the ligand ethoxybenzyl-diethylenetriamine-pentaacetic acid (EOB-DTPA). |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| PRIMOVIST Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08CA10 | Gadoxetic acid | V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 538912030009902 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02340666 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29543-12-10 |
| Country: EE | Ravimiamet | Identifier(s): 1152739, 1152740, 1152751, 1152762, 1152773, 1152784, 1152795, 1152807, 1152818 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 66648 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 018605 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 91681 |
| Country: HK | Department of Health Drug Office | Identifier(s): 54116 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-392143167 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7290415G1020, 7290415G2027 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1016494, 1016495, 1016496, 1017860, 1017861, 1017862, 1017863, 1017864, 1017865 |
| Country: MT | Medicines Authority | Identifier(s): MA1354/00301 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 15065 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100131176 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W63890001, W63890002, W63890003, W63890004, W63890005, W63890006, W63890007, W63890008, W63890009, W63890010, W63890011, W63890012, W63890013, W63890014, W63890015 |
| Country: SG | Health Sciences Authority | Identifier(s): 13308P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699546959341 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): A40/28/0001, A40/28/0003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
